HHS Offers $70 Million More in Grants Amid Opioids Crisis

"The grants we announce today clearly demonstrate our efforts to meet the opioid crisis with every tool at our disposal," said SAMHSA Acting Deputy Assistant Secretary Kana Enomoto.

The U.S. Department of Health and Human Services announced it is making more than $70 million in grants available to help communities and health care providers address the opioids crisis. Health and Human Services Secretary Tom Price announced them, saying $28 million of the total amount will be dedicated for medication-assisted treatment.

"Putting an end to the opioid crisis ravaging our country is a top priority for President Trump and all of us at the Department of Health and Human Services," he said. "We are committed to bringing everything the federal government has to bear on this health crisis. Building partnerships and providing resources to state and local governments as well as non-government organizations are absolutely critical to this effort. The purpose of these grants is to empower the heroes in this fight—the men and women on the forefront of supporting prevention, treatment, and recovery initiatives in their communities."

The money is coming from two grant funding opportunities recently authorized by the Comprehensive Addiction and Recovery Act (CARA) to expand access to overdose reversal medications and train health providers to refer patients to appropriate follow-up drug treatment, while money from a third grant funding opportunity will provide for medication-assisted treatment of opioid use disorders. This May 31 announcement followed an award of $485 million in grants in April 2017 provided by the 21st Century Cures Act to all 50 states, Washington, D.C., four U.S. territories, and the free associated states of Palau and Micronesia for opioid abuse prevention, treatment, and recovery.

"The grants we announce today clearly demonstrate our efforts to meet the opioid crisis with every tool at our disposal," said SAMHSA Acting Deputy Assistant Secretary Kana Enomoto. "The evidence-based training, medication, and behavioral therapies provided here will save lives and help people with addictions start a path toward reaching their potential."

The funding opportunity announcements are available at SAMHSA's 2017 grant announcements page.

Product Showcase

  • The MGC Simple Plus

    The MGC Simple Plus is a simple-to-use, portable multi gas detector that runs continuously for three years without being recharged or routinely calibrated after its initial charge and calibration during manufacturing. The detector reliably tests a worksite’s atmosphere for hydrogen sulfide, carbon monoxide, oxygen and combustible gases (LEL). Its durability enables the detector to withstand the harshest treatment and environments, hence earning it an IP 68 rating. The MGC Simple Plus is also compatible with a variety of accessories, such as the GCT External Pump. Visit gascliptech.com for more information. Read More

  • Full Line of Defense Against Combustible Dust Nilfisk

    Nilfisk provides a comprehensive range of industrial vacuums meticulously crafted to adhere to NFPA 652 housekeeping standards, essential for gathering combustible dust in Class I, Group D, and Class II, Groups E, F & G environments or non-classified settings. Our pneumatic vacuums are meticulously engineered to fulfill safety criteria for deployment in hazardous surroundings. Leveraging advanced filtration technology, Nilfisk ensures the secure capture of combustible materials scattered throughout your facility, ranging from fuels, solvents, and metal dust to flour, sugar, and pharmaceutical powders. Read More

  • SwabTek® Cannabis Test Kit

    The SwabTek® Cannabis Test Kit is a single-use spot test designed for use in screening for cannabis compounds in any sample type or on any surface. The test is capable of identifying the presumed presence of cannabinoids in very small quantities, with a level of detection as little as 6 μg in mass. Learn more about the SwabTek® Cannabis Test Kit and the rest of SwabTek surface drug testing solutions through the webinar titled "Everything You Want To Know About Surface Testing" Read More

Featured

Artificial Intelligence